A molecular analysis in leaves of in vitro-cultivated commercial and non-commercial Cannabis sativa genotypes

Cannabis sativa is a multipurpose crop valued for its bioactive compounds, strong and long cellulosic fibres, as well as nutritional benefits. With applications spanning different sectors, from medicine to biocomposites, it presents significant potential for pharmaceuticals, cosmetics, sustainable materials, and functional foods. This study provides a molecular characterisation of leaves from both commercial genotypes of C. sativa and non-commercial ones maintained in the germplasm collection of the Vavilov Institute of Plant Genetic Resources. The leaves were sampled from in vitro -propagated shoots cultivated on phytohormone-free medium. The targeted gene expression analysis revealed higher expression of late stage phenylpropanoid biosynthetic genes (chalcone synthase- CHS7 , flavone synthase- FNS6 , flavonoid 3′-hydroxylase- F3’H3 ) in non-commercial genotypes. In contrast, commercial genotypes showed increased expression of genes involved in the early steps of the pathway (phenylalanine ammonia lyases- PAL4 , PAL7 and 4-coumarate:coenzyme A ligase- 4CL1 ). Untargeted metabolite profiling identified > 100 differentially abundant metabolites, 92 of which belonging to flavonoids, phenolic acids, cannabinoids, lignanamides and lignans. Flavonoids, their derivatives, and cannabinoids were more abundant in non-commercial genotypes, indicating prioritisation of defence compound production. These findings highlight the potential of non-commercial genotypes as natural factories of bioactive molecules, paving the way for future applications. • Micropropagation was optimised for commercial and non-commercial Cannabis genotypes. • Leaf gene expression and metabolomics revealed distinct profiles across genotypes. • Late-step phenylpropanoid pathway genes were upregulated in non-commercial genotypes. • High flavonoid and cannabinoid levels distinguished non-commercial genotypes. • Non-commercial genotypes offer potential as factories for valuable phytochemicals.

Authors

Institutions

Publication Details

Journal
Industrial Crops and Products
Published
2025-09-22
DOI
https://doi.org/10.1016/j.indcrop.2025.121921
Citations
1
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A molecular analysis in leaves of in vitro-cultivated commercial and non-commercial Cannabis sativa genotypes

Emmanuelle Cocco, Gea Guerriero, Margaux Thiry, Kjell Sergeant et al.
1 citations
Industrial Crops and Products
Cannabis and Cannabinoid Research
1.39
article

A molecular analysis in leaves of in vitro-cultivated commercial and non-commercial Cannabis sativa genotypes

Emmanuelle Cocco, Gea Guerriero, Margaux Thiry, Kjell Sergeant, С. В. Григорьев, Stanley Lutts, Jenny Renaut, Jean-François Hausman, Marcus Iken
article en
1 citations

Abstract

Cannabis sativa is a multipurpose crop valued for its bioactive compounds, strong and long cellulosic fibres, as well as nutritional benefits. With applications spanning different sectors, from medicine to biocomposites, it presents significant potential for pharmaceuticals, cosmetics, sustainable materials, and functional foods. This study provides a molecular characterisation of leaves from both commercial genotypes of C. sativa and non-commercial ones maintained in the germplasm collection of the Vavilov Institute of Plant Genetic Resources. The leaves were sampled from in vitro -propagated shoots cultivated on phytohormone-free medium. The targeted gene expression analysis revealed higher expression of late stage phenylpropanoid biosynthetic genes (chalcone synthase- CHS7 , flavone synthase- FNS6 , flavonoid 3′-hydroxylase- F3’H3 ) in non-commercial genotypes. In contrast, commercial genotypes showed increased expression of genes involved in the early steps of the pathway (phenylalanine ammonia lyases- PAL4 , PAL7 and 4-coumarate:coenzyme A ligase- 4CL1 ). Untargeted metabolite profiling identified > 100 differentially abundant metabolites, 92 of which belonging to flavonoids, phenolic acids, cannabinoids, lignanamides and lignans. Flavonoids, their derivatives, and cannabinoids were more abundant in non-commercial genotypes, indicating prioritisation of defence compound production. These findings highlight the potential of non-commercial genotypes as natural factories of bioactive molecules, paving the way for future applications. • Micropropagation was optimised for commercial and non-commercial Cannabis genotypes. • Leaf gene expression and metabolomics revealed distinct profiles across genotypes. • Late-step phenylpropanoid pathway genes were upregulated in non-commercial genotypes. • High flavonoid and cannabinoid levels distinguished non-commercial genotypes. • Non-commercial genotypes offer potential as factories for valuable phytochemicals.

Industrial Crops and ProductsVol. 236
Luxembourg Institute of Science and Technology (LU), INTRASOFT International (Luxembourg) (LU), Vavilov Institute of General Genetics (RU), Fernand Braudel Institute of World Economics (BR), N.I. Vavilov Research Institute of Plant Industry (RU), UCLouvain (BE)
Openalex Percentile: Top 16%
Cannabis and Cannabinoid Research
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.